Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• The tumor-homing peptide LyP-1 targets tumor-associated lymphatic vessels and cells, demonstrating antitumor effects.
• Identifying the specific receptor for LyP-1 is crucial for understanding its mechanism of action and therapeutic potential.

Purpose of the Study:

• To identify the molecular receptor for the tumor-homing peptide LyP-1.
• To investigate the role of this receptor in tumor biology and its potential as a diagnostic and therapeutic target.

Main Methods:

• Fluorescence-activated cell sorting (FACS) analysis using anti-p32 antibodies.
• In vitro studies using human tumor cell lines.
• In vivo studies using xenograft tumor models.
• Immunohistochemical analysis of p32 expression in human cancers.

Main Results:

• The protein p32 (also known as gC1q receptor) was identified as the receptor for LyP-1.
• Cell-surface p32 expression was detected in various human tumor cell lines and xenograft tumors.
• LyP-1 binding and internalization correlated with cell-surface p32 levels and tumor malignancy.
• p32 antibodies localized to hypoxic tumor regions, binding to tumor cells, macrophages/myeloid cells, and tumor lymphatics.
• p32 expression was significantly elevated in human cancers compared to normal tissues.

Conclusions:

• p32 is the receptor for the LyP-1 peptide.
• Cell-surface p32 is a marker for tumor cells and tumor-associated macrophages/myeloid cells in hypoxic tumor areas.
• p32's tumor-specific localization and correlation with malignancy suggest its potential as a target for cancer diagnosis and therapy.